The AI Clinician XP2 study represents a groundbreaking approach in the field of critical care, leveraging artificial intelligence (AI) to improve treatment for sepsis patients.
This observational study, conducted across multiple intensive care units (ICUs) in the UK, aims to test the real-time application of the AI Clinician system in a clinical setting.
Client
Imperial College London
AI clinician study website
We undertook the development of the AI Clinician study website, focusing on clarity and participant comprehension.
Conveying complex information about this innovative clinical trial, which involves AI in medical decision-making, required a tailored communication strategy. The challenge lay in creating a website that not only provided essential study details but also made this high-tech approach accessible and understandable to potential participants.
The website concisely explained the study's objectives, including the use of AI to personalize medication dosages for sepsis patients and the aim to improve patient survival outcomes.
